Seng Chin Mah
Net worth: 3 M $ as of 31/07/2026
Net worth: 3 M $ as of 31/07/2026
Seng Chin Mah is currently Chairman at BioVersys AG since 2009 and Independent Director at OSR Health, Inc. starting in 2025.
Formerly, Dr. Mah was Chief Executive Officer at Canyon Pharmaceuticals, Inc. and Canyon Pharmaceuticals Group AG from 2009 to 2021, and Director at Novartis Europharm Ltd. from 1997 to 2005.
Education includes an undergraduate degree from the University of London in 1984 and a doctorate from the University of Basel in 1987.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOVERSYS AG 1.31% | 31/12/2025 | 76,358 ( 1.31% ) | 3 M $ | 31/07/2026 |
| Companies | Position | Start |
|---|---|---|
| BIOVERSYS AG | Chairman | 01/01/2009 |
| Companies | Position | End |
|---|---|---|
Canyon Pharmaceuticals, Inc.
Canyon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Chief Executive Officer | 01/01/2021 |
Canyon Pharmaceuticals Group AG
Canyon Pharmaceuticals Group AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceuticals company | Chief Executive Officer | 01/01/2021 |
Novartis Europharm Ltd.
Novartis Europharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Director/Board Member | 01/01/2005 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Canyon Pharmaceuticals, Inc.
Canyon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Canyon Pharmaceuticals Group AG
Canyon Pharmaceuticals Group AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceuticals company | Health Technology |
BioVersys AG
BioVersys AG BiotechnologyHealth Technology Engages in research and development of small molecules on novel bacterial targets with application of AMR & antibiotic drugs | Health Technology |
Novartis Europharm Ltd.
Novartis Europharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions